Cai Cun Zhou

Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy

Zhen Ye Xu, Chang Jin, Cai Cun Zhou et al. · Journal of Cancer Research and Clinical Oncology · 2011 · 59 citations · Full text

Medicine, Oncology, Pharmacology +12

Phase (Ph) II safety and efficacy results of a single-arm ph ib/II study of capmatinib (INC280) + gefitinib in patients (pts) with EGFR-mutated (mut), cMET-positive (cMET+) non-small cell lung cancer (NSCLC).

Yi‐Long Wu, Dong‐Wan Kim, Enriqueta Felip et al. · Journal of Clinical Oncology · 2016 · 46 citations

Medicine, Oncology, Pharmacology +13

Phase III Study of Selpercatinib Versus Chemotherapy ± pembrolizumab in Untreated <i>RET</i> Positive Non-Small-Cell Lung Cancer

Benjamin Solomon, Cai Cun Zhou, Alexander Drilon et al. · Future Oncology · 2020 · 37 citations · Full text

Medicine, Oncology, Pharmacology +14

[China Experts Consensus on the Diagnosis and Treatment of Advanced Stage Primary Lung Cancer (2016 Version)].

Yan Sun, Zi Ping Wang, Chang Li Wang et al. · PubMed · 2016 · 27 citations · Full text

Medicine, Oncology, Surgery +12

Atypical chemokine receptor D6 inhibits human non-small cell lung cancer growth by sequestration of chemokines

Feng Wu, Liang Tang, YIN MIN ZHAO et al. · Oncology Letters · 2013 · 19 citations · Full text

Medicine, Cancer Biology, Oncology +15